{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:29:36Z","timestamp":1786364976366,"version":"build-2736575974"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Glioblastoma (GBM) is a highly aggressive malignancy with a poor prognosis. Despite advanced molecular characterization, the traditional tumor-centric model ignores the patient\u2019s systemic body condition, which significantly influences disease progression and therapeutic outcomes. This review aims to elucidate the interactions between GBM and systemic comorbidities, focusing on metabolic, immune, and vascular networks. A key feature is activity-dependent gliomagenesis, in which neuronal firing via Neuroligin-3 (NLGN3) and glutamatergic signaling fuels tumor growth. This process confers a substantial cognitive reserve, thereby attenuating or masking early clinical manifestations via functional compensatory mechanisms; however, it may concomitantly promote rapid tumor proliferation. Overall, combined diabetes, glutamine-induced and hyperglycemia or dexamethasone-induced hyperglycemia may trigger tumor aggressive. The prothrombotic nature of GBM complicates the use of anti-angiogenic therapies. Thus, GBM and its comorbidities can be seen as metabolic-immune and vascular-cardiovascular cycles. Furthermore, chronic Hepatitis B (HBV) infection poses a unique risk of fatal reactivation during therapy in endemic regions, such as China. Consequently, real-world GBM management requires a shift from an isolated oncological to a patient-centric approach. Addressing systemic health disparities and the intrinsic interplay of comorbidities is essential to optimize treatment protocols and improve patient survival.<\/jats:p>","DOI":"10.3389\/fonc.2026.1882982","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:44:30Z","timestamp":1786362270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Review of glioblastoma and systemic comorbidities"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhang","family":"Tianqing","sequence":"first","affiliation":[{"name":"Outpatient Department, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Nursing Department, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qianyi","sequence":"additional","affiliation":[{"name":"Head & Neck Oncology Ward, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yanchu","sequence":"additional","affiliation":[{"name":"Head & Neck Oncology Ward, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2015-207002","article-title":"Socioeconomic position and the risk of brain tumour: a Swedish national population-based cohort study","volume":"70","author":"Khanolkar","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz013","article-title":"Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA","volume":"21","author":"Kuan","year":"2019","journal-title":"Neuro-Oncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-025-06594-5","article-title":"Socioeconomic influences on survival outcome in idh-wildtype glioma patients: examining the role of age, education, and lifestyle factors","volume":"167","author":"Demetz","year":"2025","journal-title":"Acta Neurochirurgica"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071393","article-title":"Dexamethasone in patients with glioblastoma: a systematic review and meta-analysis","volume":"16","author":"Scheffler","year":"2024","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s44276-024-00051-z","article-title":"Viruses in glioblastoma: an update on evidence and clinical trials","volume":"2","author":"Gunasegaran","year":"2024","journal-title":"BJC Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/bf02483449","article-title":"The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades","volume":"20","author":"Maode","year":"2003","journal-title":"Brain Tumor Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.13","article-title":"Specific inhibition of SRC kinase impairs Malignant glioma growth in vitro and in vivo","volume":"1","author":"Stedt","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030384","article-title":"AMPA receptor modulation in the treatment of high-grade glioma: translating good science into better outcomes","volume":"18","author":"Radin","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10902-8","article-title":"Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems","volume":"52","author":"Genc","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-21-0199","article-title":"Glioblastoma\u2013astrocyte connexin 43 gap junctions promote tumor invasion","volume":"20","author":"McCutcheon","year":"2022","journal-title":"Mol Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.662763","article-title":"NLGN3 upregulates expression of ADAM10 to promote the cleavage of NLGN3 via activating the LYN pathway in human gliomas","volume":"9","author":"Dang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov188","article-title":"How neuronal activity regulates glioma cell proliferation","volume":"17","author":"Filbin","year":"2015","journal-title":"Neuro-Oncology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.65","article-title":"A frightening thought: neuronal activity enhances tumor growth","volume":"25","author":"Thompson","year":"2015","journal-title":"Cell Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53360-9","article-title":"Cognitive reserve against Alzheimer\u2019s pathology is linked to brain activity during memory formation","volume":"15","author":"Vockert","year":"2024","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-021-09478-4","article-title":"Cognitive reserve, Alzheimer\u2019s neuropathology, and risk of dementia: a systematic review and meta-analysis","volume":"31","author":"Nelson","year":"2021","journal-title":"Neuropsychol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10303-w","article-title":"Cognitive impairments are independently associated with shorter survival in diffuse glioma patients","volume":"268","author":"van Kessel","year":"2020","journal-title":"J Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-026-05475-w","article-title":"Multidimensional cognitive reserve and cognitive outcomes in glioblastoma: a pre- and postoperative analysis","volume":"177","author":"Rauch","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad198","article-title":"Cognitive reserve and individual differences in brain tumour patients","volume":"5","author":"Tomasino","year":"2023","journal-title":"Brain Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature03180","article-title":"\u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Jeffrey","year":"2005","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18523","article-title":"Tumor\u2010related epilepsy in glioma: a multidisciplinary overview","volume":"66","author":"Michelucci","year":"2025","journal-title":"Epilepsia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.06.014","article-title":"Tumor-associated status epilepticus in patients with glioma: clinical characteristics and outcomes","volume":"101","author":"Giovannini","year":"2019","journal-title":"Epilepsy Behav"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-025-00455-3","article-title":"State of the art: glioma-associated epilepsy\u2014bridging tumor biology and epileptogenesis","volume":"7","author":"Div\u00e9","year":"2025","journal-title":"Neurol Res Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac003","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01553-2","article-title":"Associations between prediagnostic blood glucose levels, diabetes, and glioma","volume":"7","author":"Schwartzbaum","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17228501","article-title":"Clinical risk and overall survival in patients with diabetes mellitus, hyperglycemia and glioblastoma multiforme. a review of the current literature","volume":"17","author":"Montemurro","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.06.164","article-title":"Type 2 diabetes mellitus and glioblastoma multiforme-assessing risk and survival","volume":"106","author":"Barami","year":"2017","journal-title":"World Neurosurg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgv037","article-title":"Metabolic reprogramming and dysregulated metabolism: cause, consequence and\/or enabler of environmental carcinogenesis","volume":"36","author":"Robey","year":"2015","journal-title":"Carcinogenesis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.849279","article-title":"Type 1 insulin-like growth factor receptor nuclear localization in high-grade glioma cells enhances motility, metabolism, and in vivo tumorigenesis","volume":"13","author":"Martin","year":"2022","journal-title":"Front Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31783","article-title":"Use of metformin and survival of patients with high\u2010grade glioma","volume":"144","author":"Seliger","year":"2018","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010210","article-title":"Metformin as potential therapy for high-grade glioma","volume":"12","author":"Mazurek","year":"2020","journal-title":"Cancers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2212-1","article-title":"Glutamine addiction in gliomas","volume":"42","author":"M\u00e1rquez","year":"2017","journal-title":"Neurochem Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1712576","article-title":"Metabolism of glioblastoma: a review of metabolic adaptations and metabolic therapeutic interventions","volume":"15","author":"Chung","year":"2025","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad190","article-title":"Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression","volume":"26","author":"Boskovic","year":"2024","journal-title":"Neuro-Oncology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00644-y","article-title":"Disrupted glutamate homeostasis as a target for glioma therapy","volume":"76","author":"Biega\u0144ski","year":"2024","journal-title":"Pharmacol Rep"},{"key":"B42","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.70322\/imed.2026.10002","article-title":"Roles of astrocytes in radiation-induced brain injury: pathophysiological mechanisms and therapeutic strategies","volume":"1","author":"Wei","year":"2026","journal-title":"iMed"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020184","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of Malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00503","article-title":"Radiation-induced alterations in the recurrent glioblastoma microenvironment: therapeutic implications","volume":"8","author":"Gupta","year":"2018","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/1759091418818261","article-title":"Mitochondrial substrate-level phosphorylation as energy source for glioblastoma: review and hypothesis","volume":"10","author":"Chinopoulos","year":"2018","journal-title":"ASN Neuro"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/17590914.2024.2422268","article-title":"Amino acid and glucose fermentation maintain ATP content in mouse and human Malignant glioma cells","volume":"16","author":"Lee","year":"2024","journal-title":"ASN Neuro"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100985","article-title":"Advancing glioblastoma treatment by targeting metabolism","volume":"51","author":"Zhao","year":"2024","journal-title":"Neoplasia"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66\u2003329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos197","article-title":"Thromboembolic disease in patients with high-grade glioma","volume":"14","author":"Perry","year":"2012","journal-title":"Neuro-Oncology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/978-1-4471-4528-8_37","article-title":"Cancer-associated venous thromboembolic disease","volume":"22","author":"Michael","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.97","article-title":"Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans","volume":"110","author":"Cahoon","year":"2014","journal-title":"Br J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)00087-5","article-title":"Association between allergies and reduced risk of glioma","volume":"17","author":"Burki","year":"2016","journal-title":"Lancet Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10320","article-title":"History of allergies and autoimmune diseases and risk of brain tumors in adults","volume":"99","author":"Brenner","year":"2002","journal-title":"Int J Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2767","article-title":"Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma","volume":"9","author":"Haedenkamp","year":"2019","journal-title":"Cancer Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.epi-15-0847","article-title":"Approaching a scientific consensus on the association between allergies and glioma risk: a report from the Glioma International Case-Control Study","volume":"25","author":"Amirian","year":"2016","journal-title":"Cancer Epidemiology Biomarkers Prev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-020-00335-w","article-title":"AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer\u2014a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)","volume":"10","author":"Ferastraoaru","year":"2020","journal-title":"Clin Trans Allergy"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01768.x","article-title":"AllergoOncology: the role of IgE\u2010mediated allergy in cancer","volume":"63","author":"Jensen\u2010Jarolim","year":"2008","journal-title":"Allergy"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.238","article-title":"Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma","volume":"113","author":"Wong","year":"2015","journal-title":"Br J Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2026.105968","article-title":"The role of dexamethasone during treatment phases in glioblastoma: insights from a retrospective observational study","volume":"6","author":"G\u00f6bel","year":"2026","journal-title":"Brain Spine"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00065","article-title":"Dexamethasone in glioblastoma multiforme therapy: mechanisms and controversies","volume":"12","author":"Cenciarini","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16880","article-title":"First\u2010line antiepileptic drug treatment in glioma patients with epilepsy: levetiracetam vs valproic acid","volume":"62","author":"van der Meer","year":"2021","journal-title":"Epilepsia"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.04.016","article-title":"P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: a meta-analysis","volume":"23","author":"Yuan","year":"2014","journal-title":"Seizure"},{"key":"B67","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018\u20132022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh306","article-title":"Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients","volume":"15","author":"Houben","year":"2004","journal-title":"Ann Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2015.66","article-title":"Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat","volume":"38","author":"Letourneur","year":"2015","journal-title":"Hypertens Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122859","article-title":"Associations of general and abdominal obesity with the risk of glioma development","volume":"13","author":"Ahn","year":"2021","journal-title":"Cancers"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1667242","article-title":"Influence of diabetes on survival of patients with glioma: a meta-analysis","volume":"17","author":"Yi","year":"2026","journal-title":"Front Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genomics Proteomics Bioinf"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1126","article-title":"Prevalence of hepatitis B and C in patients with meningiomas and glioblastoma multiforme","volume":"5","author":"Cabanne","year":"2013","journal-title":"Oncol Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1882982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:44:30Z","timestamp":1786362270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1882982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":73,"alternative-id":["10.3389\/fonc.2026.1882982"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1882982","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1882982"}}